Related Experiment Video
Updated: Feb 4, 2026

Effects of Exposure of Formaldehyde to a Rat Model of Atopic Dermatitis Induced by Neonatal Capsaicin Treatment
Published on: September 27, 2017
Recent Developments in Atopic Dermatitis
Eric J Yang1,2, Sahil Sekhon3, Isabelle M Sanchez3,4
1Department of Dermatology, University of California, San Francisco, San Francisco, California; ericjyang@outlook.com.
Insights
Atopic dermatitis (AD) affects many children, impacting their quality of life. New research is improving understanding and treatment options for this common skin condition.
Area of Science:
- Dermatology
- Pediatrics
- Immunology
Background:
- Atopic dermatitis (AD) is a prevalent skin condition in US children, affecting approximately 10.7%.
- AD significantly diminishes the quality of life for affected children and their families.
- Pediatricians play a crucial role in diagnosing and managing pediatric AD.
Purpose of the Study:
- To review current guidelines for managing atopic dermatitis in children.
- To outline recent advancements in understanding AD pathophysiology.
- To highlight novel therapeutic developments for atopic dermatitis.
Main Methods:
- Literature review of current AD management guidelines.
- Analysis of recent research on AD pathogenesis.
- Survey of emerging treatments for atopic dermatitis.
Main Results:
- Current guidelines provide a framework for AD management.
- New insights into AD pathogenesis are rapidly emerging.
- Novel therapies for AD are under development.
Conclusions:
- The management landscape for pediatric atopic dermatitis is evolving.
- Continued research is crucial for understanding and treating AD.
- Novel therapeutic strategies offer new hope for managing this burdensome disease.
Abstract:
Atopic dermatitis (AD) is a bothersome and common skin disease affecting ∼10.7% of children in the United States. This skin condition significantly decreases quality of life in not only patients, but in their families as well. Pediatricians are often the first physicians to diagnose and manage these patients and thus are relied on by families to answer questions about this disease. AD is complex, multifactorial, and has historically had limited therapeutic options, but the landscape of this disease is now rapidly changing. Pathways contributing to the pathogenesis of this disease are continually being discovered, and new therapies for AD are being developed at an unprecedented rate. With this article, we will review the current guidelines regarding the management of AD, outline updates in the current understanding of its pathophysiology, and highlight novel developments available for the treatment of this burdensome disease.
Related Concept Videos
Sustainable Development
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...
Fruit Development, Structure, and Function

